Gustavo A. Rosario Benitez

Array ( [id] => 6761252 [patent_doc_number] => 20030124614 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-07-03 [patent_title] => 'Novel T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof' [patent_app_type] => new [patent_app_number] => 10/145012 [patent_app_country] => US [patent_app_date] => 2002-05-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 19335 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20030124614.pdf [firstpage_image] =>[orig_patent_app_number] => 10145012 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6429031 [patent_doc_number] => 20020127201 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-12 [patent_title] => 'Methods for inhibiting T cell responses by manipulating a common cytokine receptor gamma-chain' [patent_app_type] => new [patent_app_number] => 10/141199 [patent_app_country] => US [patent_app_date] => 2002-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 14582 [patent_no_of_claims] => 47 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0127/20020127201.pdf [firstpage_image] =>[orig_patent_app_number] => 10141199 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 359435 [patent_doc_number] => 07485314 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-03 [patent_title] => 'Induction of antigen specific immunologic tolerance' [patent_app_type] => utility [patent_app_number] => 10/141668 [patent_app_country] => US [patent_app_date] => 2002-05-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 15953 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 173 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/485/07485314.pdf [firstpage_image] =>[orig_patent_app_number] => 10141668 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6773814 [patent_doc_number] => 20030017152 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Non-lethal methods for conditioning a recipient for bone marrow transplantation' [patent_app_type] => new [patent_app_number] => 10/134016 [patent_app_country] => US [patent_app_date] => 2002-04-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12292 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 65 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0017/20030017152.pdf [firstpage_image] =>[orig_patent_app_number] => 10134016 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6557882 [patent_doc_number] => 20020194631 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-12-19 [patent_title] => 'Method of treating psoriasis using anti-interleukin 12 antibody' [patent_app_type] => new [patent_app_number] => 10/108191 [patent_app_country] => US [patent_app_date] => 2002-03-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 14637 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20020194631.pdf [firstpage_image] =>[orig_patent_app_number] => 10108191 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7152446 [patent_doc_number] => 20050025743 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-02-03 [patent_title] => 'Method of preventing adhesions wtih ifn-upsilon' [patent_app_type] => utility [patent_app_number] => 10/471892 [patent_app_country] => US [patent_app_date] => 2002-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4930 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20050025743.pdf [firstpage_image] =>[orig_patent_app_number] => 10471892 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6817362 [patent_doc_number] => 20030068320 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-04-10 [patent_title] => 'Methods of administering/dosing CD2 antagonists for the prevention and treatment of autoimmune disorders or inflammatory disorders' [patent_app_type] => new [patent_app_number] => 10/091268 [patent_app_country] => US [patent_app_date] => 2002-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 66692 [patent_no_of_claims] => 60 [patent_no_of_ind_claims] => 26 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0068/20030068320.pdf [firstpage_image] =>[orig_patent_app_number] => 10091268 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6749886 [patent_doc_number] => 20030044406 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-06 [patent_title] => 'Methods of preventing or treating inflammatory or autoimmune disorders by administering CD2 antagonists in combination with other prophylactic or therapeutic agents' [patent_app_type] => new [patent_app_number] => 10/091313 [patent_app_country] => US [patent_app_date] => 2002-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 80847 [patent_no_of_claims] => 71 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0044/20030044406.pdf [firstpage_image] =>[orig_patent_app_number] => 10091313 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6834283 [patent_doc_number] => 20030161828 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-08-28 [patent_title] => 'Use of TNF antagonists as drugs for the treatment of patients with an inflammatory reaction and without suffering from total organ failure' [patent_app_type] => new [patent_app_number] => 10/079776 [patent_app_country] => US [patent_app_date] => 2002-02-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4524 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 42 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20030161828.pdf [firstpage_image] =>[orig_patent_app_number] => 10079776 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6159514 [patent_doc_number] => 20020147312 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-10-10 [patent_title] => 'Hybrid antibodies and uses thereof' [patent_app_type] => new [patent_app_number] => 10/060714 [patent_app_country] => US [patent_app_date] => 2002-01-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 24856 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0147/20020147312.pdf [firstpage_image] =>[orig_patent_app_number] => 10060714 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6774836 [patent_doc_number] => 20030018174 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-01-23 [patent_title] => 'Monoclonal antibodies to IFNAR2' [patent_app_type] => new [patent_app_number] => 10/053302 [patent_app_country] => US [patent_app_date] => 2002-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 28231 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0018/20030018174.pdf [firstpage_image] =>[orig_patent_app_number] => 10053302 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7675755 [patent_doc_number] => 20040126363 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-01 [patent_title] => 'Cd19-specific redirected immune cells' [patent_app_type] => new [patent_app_number] => 10/416011 [patent_app_country] => US [patent_app_date] => 2003-05-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 17605 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0126/20040126363.pdf [firstpage_image] =>[orig_patent_app_number] => 10416011 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7399705 [patent_doc_number] => 20040023340 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-05 [patent_title] => 'Method for producing human anti-thymocyte immunoglobulins' [patent_app_type] => new [patent_app_number] => 10/381859 [patent_app_country] => US [patent_app_date] => 2003-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2575 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 24 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0023/20040023340.pdf [firstpage_image] =>[orig_patent_app_number] => 10381859 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6554531 [patent_doc_number] => 20020164331 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-11-07 [patent_title] => 'Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations' [patent_app_type] => new [patent_app_number] => 09/885768 [patent_app_country] => US [patent_app_date] => 2001-06-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 29609 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 24 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0164/20020164331.pdf [firstpage_image] =>[orig_patent_app_number] => 09885768 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 133302 [patent_doc_number] => 07696338 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Immunotoxin fusion proteins and means for expression thereof' [patent_app_type] => utility [patent_app_number] => 10/296085 [patent_app_country] => US [patent_app_date] => 2001-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 54 [patent_figures_cnt] => 60 [patent_no_of_words] => 58158 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696338.pdf [firstpage_image] =>[orig_patent_app_number] => 10296085 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 70868 [patent_doc_number] => 07754217 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-13 [patent_title] => 'HMGB1 protein inhibitors and/or antagonists for the treatment of vascular diseases' [patent_app_type] => utility [patent_app_number] => 10/471641 [patent_app_country] => US [patent_app_date] => 2001-03-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 10 [patent_no_of_words] => 6543 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/754/07754217.pdf [firstpage_image] =>[orig_patent_app_number] => 10471641 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 13398 [patent_doc_number] => 07807463 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-10-05 [patent_title] => 'Pre-transplant accommodated organs resistant to anti-donor immunity' [patent_app_type] => utility [patent_app_number] => 10/181896 [patent_app_country] => US [patent_app_date] => 2001-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 11474 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 103 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/807/07807463.pdf [firstpage_image] =>[orig_patent_app_number] => 10181896 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 80512 [patent_doc_number] => 07744863 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2010-06-29 [patent_title] => 'Method of inducing immune tolerance' [patent_app_type] => utility [patent_app_number] => 10/148010 [patent_app_country] => US [patent_app_date] => 2000-11-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10530 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 78 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/744/07744863.pdf [firstpage_image] =>[orig_patent_app_number] => 10148010 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 840302 [patent_doc_number] => 07390630 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2008-06-24 [patent_title] => 'Method of identifying a compound that selectively inhibits cytokine-stimulated T cell induced production of TNF-alpha by monocytes' [patent_app_type] => utility [patent_app_number] => 10/088801 [patent_app_country] => US [patent_app_date] => 2000-09-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 7 [patent_no_of_words] => 18785 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 248 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/390/07390630.pdf [firstpage_image] =>[orig_patent_app_number] => 10088801 [rel_patent_id] =>[rel_patent_doc_number] =>)